| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.800 | None | 0.970 | 40 | 0 | 1987 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 1.000 | None | 0.967 | 14 | 3 | 1983 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 1.000 | None | 0.985 | 9 | 8 | 2001 | 2020 | ||||||||
|
colony stimulating factor 3 | 0.377 | 0.885 | 0.38 |
|
disease | 0.400 | None | 1.000 | 8 | 0 | 1993 | 2019 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.800 | None | 0.963 | 7 | 139 | 2001 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.970 | 6 | 0 | 1987 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.971 | 6 | 0 | 1990 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 1.000 | None | 0.973 | 6 | 9 | 1982 | 2020 | ||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.800 | None | 0.970 | 6 | 221 | 2006 | 2020 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
disease | 0.400 | None | 0.980 | 5 | 0 | 1993 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.957 | 5 | 0 | 1998 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.600 | None | 0.906 | 4 | 0 | 1986 | 2018 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.955 | 4 | 0 | 1998 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.400 | None | 0.896 | 4 | 0 | 1995 | 2019 | ||||||||
|
DNA topoisomerase II alpha | 0.497 | 0.731 | 0.99 |
|
disease | 0.400 | None | 0.974 | 4 | 0 | 1999 | 2019 | ||||||||
|
vimentin | 0.372 | 0.846 | 0.71 |
|
disease | 0.400 | None | 0.967 | 4 | 0 | 1989 | 2020 | ||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
disease | 0.800 | None | 0.951 | 4 | 99 | 2001 | 2020 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.600 | None | 0.979 | 4 | 0 | 2004 | 2019 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
disease | 0.800 | None | 0.977 | 4 | 1 | 1999 | 2019 | ||||||||
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3B | 0.547 | 0.731 | 5.2E-16 |
|
disease | 0.400 | None | 0.967 | 4 | 0 | 2010 | 2019 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.400 | None | 0.825 | 3 | 0 | 1997 | 2019 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.400 | None | 0.980 | 3 | 0 | 1985 | 2019 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.600 | None | 0.970 | 3 | 0 | 1996 | 2020 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.942 | 3 | 11 | 1991 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1991 | 2020 |